There was no claim about reformulation in MRK's PR, so I presume the drug is unchanged. Moreover, a reformulation would presumably require a bridging study in addition to a new phase-3.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”